This trial will evaluate the effects of a 7-day course of hydrocortisone therapy on
short-term morbidity, cardiovascular function, long-term neurodevelopment, and mortality in
critically ill, term and late preterm infants diagnosed with cardiovascular insufficiency as
defined by a need for inotrope therapy in the first 72 hours of age.
Phase:
Phase 3
Details
Lead Sponsor:
NICHD Neonatal Research Network
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Center for Research Resources (NCRR)